Bone marrow and stem cell transplants offer a line of hope for people diagnosed with a complex cancer or blood disorder. We’re proud to be home to several breakthroughs for transplants and will pursue what’s next for you on your wellness journey.
Caring is part of our DNA
When it comes to making the very important decision of where to receive care for your cancer or blood disorder, you can feel confident knowing that your health is in safe hands at Tufts Medicine.
Compassionate, cutting-edge care is part of our DNA. From pioneering "mini-transplants" for patients who can't tolerate "full" transplants to performing Boston's first bone marrow transplant at Tufts Medical Center in the 1950s, we've helped thousands of people with life-saving bone marrow and stem cell transplants.
Our team performs transplants using bone marrow, peripheral blood stem cells (PBSCs) and umbilical cord blood. We’ll work with you to identify the best treatment options for your condition.
A bone marrow transplant uses stem cells sourced from different people and places.
- An autologous transplant is sourced from your body.
- An allogeneic transplant is sourced from a family member or donor who is the right match.
- A haploidentical allogeneic transplant is sourced from a family member who is a half-match to you.
Therapeutic cell therapy
People living with a complex cancer or blood disorder may also benefit from therapeutic cell therapy, known as chimeric antigen receptor T-cell therapy (CAR-T). This state-of-the-art therapy uses T cells (immune cells) to target and destroy cancer.
We achieve this by genetically engineering T cells in the lab to detect and destroy cancer cells and then transferring them to the patient’s body.
CAR-T is for people with the following relapsed or refractory conditions:
- Acute Lymphocytic Leukemia (for people younger than age 26)
- Diffuse Large B Cell Lymphoma (for people age 18 and older)
People with other diagnoses — including multiple myeloma — may be candidates for available CAR-T clinical trials.